The Beauty Health Company Reports Record Fourth Quarter and Fiscal Year 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- Harry and Meghan surprised by King Charles' letter on their status
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Qualcomm to issue warrant to Amazon for up to 25M shares
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
The Beauty Health Company (SKIN) PT Raised to $35 at DA Davidson
February 23, 2022 11:59 AM ESTDA Davidson analyst Linda Bolton Weiser raised the price target on The Beauty Health Company (NASDAQ: SKIN) to $35.00 (from $32.00) while maintaining a Buy rating following results.
The analyst commented, "Although SKIN had pre-announced on January 10th that 4Q21 would be in line, it... More
The Beauty Health Company (SKIN) Misses Q4 EPS by 10c, Revenue Beats, Offers Guidance
February 22, 2022 4:16 PM ESTThe Beauty Health Company (NASDAQ: SKIN) reported Q4 EPS of ($0.12), $0.10 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $77.9 million versus the consensus estimate of $71.1 million.
GUIDANCE:
The Beauty Health Company sees 2022 revenue of $320-330 million, versus... More
